Literature DB >> 19152698

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department.

Rico Fiumefreddo1, Roya Zaborsky, Jeannine Haeuptle, Mirjam Christ-Crain, Andrej Trampuz, Ingrid Steffen, Reno Frei, Beat Müller, Philipp Schuetz.   

Abstract

BACKGROUND: Legionella species cause severe forms of pneumonia with high mortality and complication rates. Accurate clinical predictors to assess the likelihood of Legionella community-acquired pneumonia (CAP) in patients presenting to the emergency department are lacking.
METHODS: We retrospectively compared clinical and laboratory data of 82 consecutive patients with Legionella CAP with 368 consecutive patients with non-Legionella CAP included in two studies at the same institution.
RESULTS: In multivariate logistic regression analysis we identified six parameters, namely high body temperature (OR 1.67, p < 0.0001), absence of sputum production (OR 3.67, p < 0.0001), low serum sodium concentrations (OR 0.89, p = 0.011), high levels of lactate dehydrogenase (OR 1.003, p = 0.007) and C-reactive protein (OR 1.006, p < 0.0001) and low platelet counts (OR 0.991, p < 0.0001), as independent predictors of Legionella CAP. Using optimal cut off values of these six parameters, we calculated a diagnostic score for Legionella CAP. The median score was significantly higher in Legionella CAP as compared to patients without Legionella (4 (IQR 3-4) vs 2 (IQR 1-2), p < 0.0001) with a respective odds ratio of 3.34 (95%CI 2.57-4.33, p < 0.0001). Receiver operating characteristics showed a high diagnostic accuracy of this diagnostic score (AUC 0.86 (95%CI 0.81-0.90), which was better as compared to each parameter alone. Of the 191 patients (42%) with a score of 0 or 1 point, only 3% had Legionella pneumonia. Conversely, of the 73 patients (16%) with > or =4 points, 66% of patients had Legionella CAP.
CONCLUSION: Six clinical and laboratory parameters embedded in a simple diagnostic score accurately identified patients with Legionella CAP. If validated in future studies, this score might aid in the management of suspected Legionella CAP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152698      PMCID: PMC2636761          DOI: 10.1186/1471-2466-9-4

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  24 in total

Review 1.  Can Legionnaires disease be diagnosed by clinical criteria? A critical review.

Authors:  L Mulazimoglu; V L Yu
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

2.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

3.  Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system.

Authors:  Núria Fernández-Sabé; Beatriz Rosón; Jordi Carratalà; Jordi Dorca; Frederic Manresa; Francesc Gudiol
Journal:  Clin Infect Dis       Date:  2003-07-28       Impact factor: 9.079

4.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

5.  New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases.

Authors:  G D Fang; M Fine; J Orloff; D Arisumi; V L Yu; W Kapoor; J T Grayston; S P Wang; R Kohler; R R Muder
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

6.  Atypical pneumonias. Clinical diagnosis and empirical treatment.

Authors:  B A Cunha
Journal:  Postgrad Med       Date:  1991-10       Impact factor: 3.840

7.  Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia.

Authors:  S K Gupta; T F Imperiale; G A Sarosi
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

8.  Onset and duration of urinary antigen excretion in Legionnaires disease.

Authors:  R B Kohler; W C Winn; L J Wheat
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Growth of 28 Legionella species on selective culture media: a comparative study.

Authors:  T C Lee; R M Vickers; V L Yu; M M Wagener
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Legionella pneumophila. A cause of severe community-acquired pneumonia.

Authors:  V Falcó; T Fernández de Sevilla; J Alegre; A Ferrer; J M Martínez Vázquez
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

View more
  36 in total

1.  Legionella Pneumophilla Infection Masquerading as Acute Cholecystitis.

Authors:  Dimitrios Anyfantakis; Vasiliki Krietsepi; Aggeliki Damianaki; Emmanouil K Symvoulakis; Argiro Gogou; Eirini Pasparaki; Serafim Kastanakis
Journal:  Maedica (Buchar)       Date:  2015-09

Review 2.  Pancreatic involvement in Legionella pneumonia.

Authors:  S Franchini; A Marinosci; L Ferrante; M G Sabbadini; M Tresoldi; L Dagna
Journal:  Infection       Date:  2015-01-10       Impact factor: 3.553

3.  Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia.

Authors:  Naoyuki Miyashita; Futoshi Higa; Yosuke Aoki; Toshiaki Kikuchi; Masafumi Seki; Kazuhiro Tateda; Nobuko Maki; Kazuhiro Uchino; Hiroshi Kiyota; Akira Watanabe
Journal:  J Infect Chemother       Date:  2022-07-08       Impact factor: 2.065

4.  The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection.

Authors:  José C de La Flor; Ana Gomez-Berrocal; Alexander Marschall; Francisco Valga; Tania Linares; Cristina Albarracin; Elisa Ruiz; Gioconda Gallegos; Alberto Gómez; Andrea de Los Santos; Miguel Rodeles
Journal:  Med Clin (Engl Ed)       Date:  2022-06-29

5.  Legionnaires' disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: a case report.

Authors:  Toyoaki Sawano; Masaharu Tsubokura; Akihiko Ozaki; Claire Leppold; Shigeaki Kato; Toshiyuki Kambe
Journal:  J Occup Health       Date:  2018-09-27       Impact factor: 2.708

6.  Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Authors:  Shawna Bellew; Carlos G Grijalva; Derek J Williams; Evan J Anderson; Richard G Wunderink; Yuwei Zhu; Grant W Waterer; Anna M Bramley; Seema Jain; Kathryn M Edwards; Wesley H Self
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

Review 7.  Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations.

Authors:  Priscilla Kim; Abhishek Deshpande; Michael B Rothberg
Journal:  Infect Drug Resist       Date:  2022-04-27       Impact factor: 4.177

8.  Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Authors:  Philipp Schuetz; Sebastian Haubitz; Mirjam Christ-Crain; Werner C Albrich; Werner Zimmerli; Beat Mueller
Journal:  BMC Infect Dis       Date:  2013-12-11       Impact factor: 3.090

9.  The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children.

Authors:  Yongdong Yan; Yuzhen Wei; Wujun Jiang; Chuangli Hao
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

Review 10.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.